Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Verticchio Vercellin

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Glaucoma|July 1, 2026
The Future of Glaucoma: Data, AI, and Precision Medicine for Patient-Centered CareAlice Verticchio Vercellin, Keren Wood, Louis R Pasquale, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
Cardiac Surgery Patients Have Reduced Vascularity and Structural Defects of the Retina Similar to Persons with Open-Angle GlaucomaGabija Vičaitė, Liveta Barišauskaitė, Viktorija Bakstytė, et al.
Genes|August 27, 2021
Glaucoma Heritability: Molecular Mechanisms of DiseaseRyan Zukerman, Alon Harris, Francesco Oddone, et al.
Journal of Clinical Medicine|May 14, 2022
Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?Aditya Belamkar, Alon Harris, Francesco Oddone, et al.
Genes|January 5, 2021
Molecular Genetics of Glaucoma: Subtype and Ethnicity ConsiderationsRyan Zukerman, Alon Harris, Alice Verticchio Vercellin, et al.
Journal of Glaucoma|December 22, 2023
Lessons From The Glaucoma Foundation Think Tank 2023: A Patient-Centric Approach to GlaucomaAlon Harris, Alice Verticchio Vercellin, Robert N Weinreb, et al.
Journal of Clinical Medicine|March 10, 2022
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative ReviewAlice Verticchio Vercellin, Alon Harris, Ari M Stoner, et al.
European Journal of Ophthalmology|June 2, 2020
Ocular side effects of target therapy and immunotherapy in patients with cutaneous malignant melanomaJennifer Eikenberry, Alon Harris, Rana Torabi, et al.
Expert Opinion on Therapeutic Targets|January 21, 2022
Disease progression pathways of wet AMD: opportunities for new target discoveryAmber T Wolf, Alon Harris, Francesco Oddone, et al.
Annals of Medicine|January 25, 2022
Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medicationsAditya Belamkar, Alon Harris, Ryan Zukerman, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Glaucoma|July 1, 2026
The Future of Glaucoma: Data, AI, and Precision Medicine for Patient-Centered CareAlice Verticchio Vercellin, Keren Wood, Louis R Pasquale, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
Cardiac Surgery Patients Have Reduced Vascularity and Structural Defects of the Retina Similar to Persons with Open-Angle GlaucomaGabija Vičaitė, Liveta Barišauskaitė, Viktorija Bakstytė, et al.
Genes|August 27, 2021
Glaucoma Heritability: Molecular Mechanisms of DiseaseRyan Zukerman, Alon Harris, Francesco Oddone, et al.
Journal of Clinical Medicine|May 14, 2022
Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?Aditya Belamkar, Alon Harris, Francesco Oddone, et al.
Genes|January 5, 2021
Molecular Genetics of Glaucoma: Subtype and Ethnicity ConsiderationsRyan Zukerman, Alon Harris, Alice Verticchio Vercellin, et al.
Journal of Glaucoma|December 22, 2023
Lessons From The Glaucoma Foundation Think Tank 2023: A Patient-Centric Approach to GlaucomaAlon Harris, Alice Verticchio Vercellin, Robert N Weinreb, et al.
Journal of Clinical Medicine|March 10, 2022
Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative ReviewAlice Verticchio Vercellin, Alon Harris, Ari M Stoner, et al.
European Journal of Ophthalmology|June 2, 2020
Ocular side effects of target therapy and immunotherapy in patients with cutaneous malignant melanomaJennifer Eikenberry, Alon Harris, Rana Torabi, et al.
Expert Opinion on Therapeutic Targets|January 21, 2022
Disease progression pathways of wet AMD: opportunities for new target discoveryAmber T Wolf, Alon Harris, Francesco Oddone, et al.
Annals of Medicine|January 25, 2022
Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medicationsAditya Belamkar, Alon Harris, Ryan Zukerman, et al.
Pageof 4